Human Genome Sciences, Inc. (Nasdaq: HGSI) announced an exclusive worldwide licensing agreement with Novartis (NYSE: NVS) for the development and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE